Citations with the tag: PFIZER Inc
Results 1 - 50
- Pfizer to add to field force, other firms likely to do same.
// Medical Marketing & Media; Sep97, Vol. 32 Issue 9, p16
Reports on plans by Pfizer Inc. to increase th size of its specialist sales forces and establish another primary-care field force in the United States. Number of sales representatives to be added by January 1998.
- Roerig remembered: A crucible that forged remarkable business careers.
Tate, Jim // Medical Marketing & Media; Jan1998, Vol. 33 Issue 1, p66
Focuses on the success of employees who once worked at the old Roerig division of Pfizer Inc. in the 1960s and 1970s in healthcare business. History of the Roerig division; Employees' attribution of their success to the disciplined system of operating a business; Overview on the career success...
- Pfizer's aim to be number one is almost within reach.
Seiden, Carl // Medical Marketing & Media; Jun98, Vol. 33 Issue 6, p54
Presents information on the advancements being made by the Pfizer company, in the pharmaceutical industry. Background information on the company; Number of products marketed by Pfizer; Statistical information on Pfizer's annual change in research and development spending.
- South of the border.
Seiden, Carl // Beverage Industry; Nov95, Vol. 86 Issue 11, p46
Reports on the launching of `Aclame' the next-generation high performance sweetener developed by Pfizer Food Science at ceremonies held in Mexico City.
- Pfizer completes technical services expansion.
Seiden, Carl // Candy Industry; Jul95, Vol. 160 Issue 7, p23
Reports on completed expansion of the technical services center of Pfizer Food Science Group. Addition of laboratories and improved office and meeting spaces; Inclusion of pilot facilities for baked good and confections; Availability of video conferencing and video taping facilities.
- Pfizer adds flavor.
Seiden, Carl // Chemical Week; 9/13/95, Vol. 157 Issue 9, p35
Reports that the Pfizer Food Science Group will offer natural maltol under its Veltol flavor ingredient product line in early 1996.
- Pfizer seeks new alliances.
Seiden, Carl // Drug Topics; 11/8/93, Vol. 137 Issue 21, p6
Announces the plans of Pfizer Inc. to explore acquisitions and partners. Competitiveness in future health care plan of President Clinton; Generics as a possible project.
- Pfizer on MC bandwagon.
Seiden, Carl // Drug Topics; 2/7/94, Vol. 138 Issue 3, p86
Reports on Pfizer Inc.'s reorganization of its marketing and sales operations. Emphasis on sales to managed care organizations; Establishment of two main marketing groups.
- Natural Veltol.
Seiden, Carl // Snack Food; Nov95, Vol. 84 Issue 11, p46
Reports on Pfizer Food Science Group's addition of Natural Veltol to its family of Veltol flavor ingredients.
- Pfizer's new investment strategy concentrates on genetic research.
Seiden, Carl // Westchester County Business Journal; 4/3/95, Vol. 34 Issue 14, p13
No abstract available.
- Pfizer looking to build new conference center.
Philippidis, Alex // Westchester County Business Journal; 12/16/96, Vol. 35 Issue 51, p3
Reports on the search by Pfizer Inc. in Westchester County, New York State, Connecticut's Fairfield county and other sites in the metropolitan area for a site where it can build a conference center. Reason for the search; Features of the conference center of the company in New York City;...
- Long-Awaited Torcetrapib Will Not Be Released, Too Risky.
Elliot, William T. // Critical Care Alert; May2007 Pharmacology Watch, p1
The article reports that the development of torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been discontinued by Pfizer.
- Governors honor Pfizer for sharing.
Elliot, William T. // Drug Topics; 8/18/97, Vol. 141 Issue 16, p8
Reports on the citation of Pfizer's `Sharing the Care' program, which provides prescription drugs for the poor by the National Governors Association. Details on the program.
- Cooperation was key in Pfizer's decision to build center in Rye Brook.
Philippidis, Alex // Westchester County Business Journal; 12/22/97, Vol. 36 Issue 51, p6
Reports on the economic incentives that convinced Pfizer Inc. officials to build a conference center in Rye Brook, New York. Competition with New Jersey for the building project; Expansion of the company's workforce; Consolidation of the Westchester and Palisades training sites.
- Pfizer eyes pact.
Harrington, John // Crain's New York Business; 2/14/94, Vol. 10 Issue 7, p26
Reports on Pfizer Inc.'s plan to form an alliance with rival drug companies that would see a pool of prescription medicines to increasingly powerful pharmaceutical buyers. Result.
- Pfizer buys Bain.
Harrington, John // Crain's New York Business; 8/21/95, Vol. 11 Issue 34, p30
Reports that Pfizer Inc. has acquired the Bain de Soleil skin-care line from Procter & Gamble. Value of consumer-product purchases of Pfizer in 1994.
- Pfizer solos amid mergers.
Benson, Barbara // Crain's New York Business; 8/28/95, Vol. 11 Issue 35, p1
Reports on the refusal of Pfizer Inc. to merge with other companies despite the increasing number of mergers and consolidation among other drug companies. Continued success of the company's research and product development; Commitment of the company to remain independent.
- Pfizer examines local sites for new conference center.
Philippidis, Alex // Fairfield County Business Journal; 12/16/96, Vol. 35 Issue 51, p1
Reports that Pfizer Inc. is searching for a site where it cal build a new conference center. Plans to replace the company's venue in New York city; Background information on the company; Information on the Thornwood Conference Center; Comments from spokesman Andy McCormick.
- Agencies line up for pan-Euro Viagra brief.
Williams, Matt // Campaign (UK); 1/28/2011, Issue 4, p1
The article reports on the move of Pfizer Inc. to look an agency which would manage a pan-European advertising campaigns of Viagra brand in Great Britain.
- Pfizer seeking ideas from agencies on image campaign.
Comiteau, Jennifer // Adweek Eastern Edition; 1/12/1998, Vol. 39 Issue 2, p5
Reveals Pfizer's search for ideas from advertising agencies on its proposed image campaign. Budget appropriated by the company for the campaign.
- 3 Pfizer drugs hit $3 billion in sales.
Ruano, Lida Estela // Caribbean Business; 5/16/1996, Vol. 24 Issue 19, p12
States that in Puerto Rico, Pfizer Pharmaceuticals Incorporated's (PPI) three best selling drugs, Procardia XL, Zoloft and Norvasc, recorded sales of one billion dollars each in 1995. What the drugs are used for; Number of employees; Where the company is located; What is the company's secret...
- Pfizer moves accounts in Australia.
Ruano, Lida Estela // Adweek Western Edition; 7/19/93, Vol. 43 Issue 29, p15
Reports on the transfer by Pfizer of its advertising accounts in Australia to other agencies. Visine and Rectinol brands to Healthcom; Combantrin and hair lice products contract to the Saatchi & Saatchi.
- Pfizer to raise spending.
Harrington, John // Crain's New York Business; 3/20/95, Vol. 11 Issue 12, p34
Reports that Pfizer Inc. will increase its research investments in the development of new drugs.
- Pfizer to cut 4,000.
Harrington, John // Crain's New York Business; 10/25/93, Vol. 9 Issue 43, p54
Reports on Pfizer Inc.'s plan of cutting jobs worldwide. Number of workers in Manhattan and Brooklyn, New York City; Pressure on pharmaceutical prices; Competition from managed care companies.
- Ben Gay gets irritable.
Mehegan, Sean // Brandweek; 06/23/97, Vol. 38 Issue 25, p12
Reports on the introduction of Ben Gay Capsaicin, by Pfizer. Description of capsaicin; How the product will be advertised; Comments from Doug Sweetbaum, skincare category director at Pfizer.
- New Pfizer Animal Health becomes industry giant.
Bernick, Karen // Agri Marketing; Sep95, Vol. 33 Issue 8, p48
Discusses how Pfizer Animal Health, the result of Pfizer Inc.'s acquisition of Smithkline Beecham Animal Health, became an industry giant. Team approach; Livestock markets; Effect on Pfizer's ability to serve dog, cat and horse owners; Core teams; Evaluating teams. INSET: Pfizer and Smithkline...
- Fixing flavor.
Bernick, Karen // Snack Food; May95, Vol. 84 Issue 5, p48
Presents Pfizer Food Science Group's new literature for its Veltol brand flavor ingredients. Outline of Veltol ingredients' abilities; Applications for Veltol.
- Pfizer approval for Zyrtec.
Bernick, Karen // Chemical Week; 4/19/1995, Vol. 156 Issue 15, p8
Reports on Food and Drug Administration approval for Pfizer to sell UCB of Belgium's allergy drug Zyrtec.
- Food additives.
Bernick, Karen // Chemical Week; 7/26/1995, Vol. 157 Issue 3, p59
Reports on a major expansion completed by Pfizer's Food Science group. Addition of new production line for Litesse bulking agents; Plan additions of Chy-Max coagulants capacity expansion.
- Pfizer takes bids for Food Science.
Fattah, Hassan // Chemical Week; 9/20/1995, Vol. 157 Issue 10, p14
Reports on Pfizer's acceptance of bids for its Food Science division. Speculations on inquiry from companies; Estimated value of the division; Expected value of bids.
- Pfizer stock.
Fattah, Hassan // Crain's New York Business; 8/23/93, Vol. 9 Issue 34, p42
Reports on the transfer of ten million shares of common stock by Pfizer Inc. into a trust to fund employee benefit plans. Lack of effect on company's program to repurchase 20 million shares.
- As Pfizer ponders breakup, which brands will sell?
Arnold, Matthew // Medical Marketing & Media; Apr2011, Vol. 46 Issue 4, p8
The article reports on the issues concerning the plan of Pfizer Inc. to sell some of its major brands in the U.S.
- New Pfizer drug.
Arnold, Matthew // Crain's New York Business; 07/21/97, Vol. 13 Issue 29, p54
Reports that Pfizer Incorporated will test its antibiotic azithromycin on heart attack survivors. Views of researchers in Britain who used the antibiotic.
- Pfizer net declines.
Desai, Suresh Thakur // Chemical Business; Dec97, Vol. 11 Issue 5, p25
Cites the financial performance of Pfizer Ltd. during the first half year ended September 30, 1997.
- Pfizer donates drugs.
Desai, Suresh Thakur // Nature; 8/26/1993, Vol. 364 Issue 6440, p746
Details Pfizer Inc.'s `Sharing the Care' program. Clinton Administration's view that pharmaceuticals are contributing to the high cost of health care; Donation of drugs to the poor and homeless.
- Pfizer seeks partners.
Harrington, John // Crain's New York Business; 11/1/93, Vol. 9 Issue 44, p66
Reports on Manhattan-based drug maker Pfizer Inc.'s move to pursue acquisitions and alliance to guarantee its presence in the health-care system. Reaction to President Bill Clinton's health care reform act; Partnerships with manage-care companies.
- Dosage data too favorable in Zyrtec promotion.
Dickinson, James G. // Medical Marketing & Media; Aug97, Vol. 32 Issue 8, p38
Focuses on CDER Division of Drug Marketing, Advertising and Communications lawyer Joan Hankin's criticism against Pfizer's used of data from a comparative study to justify the additional dosage involving its Zyrtec. Hankin's recommendation for Pfizer to stop the use of promotional material...
- Zithromax DTC public service-product combo ad scheduled.
Dickinson, James G. // Medical Marketing & Media; Sep97, Vol. 32 Issue 9, p22
Reports on Pfizer Inc.'s impending launch of a direct-to-consumer print advertising program for its Zithromax antibiotic. Combination of a public education message on antibiotic use on one page, facing a page featuring physician advisory about Zithromax; Hiring of Euro RSCG and its public...
- Pfizer DTC program reaches patients in the pharmacy.
Dickinson, James G. // Medical Marketing & Media; Nov97, Vol. 32 Issue 11, p8
Reports on Pfizer Health Solutions' arrangement to provide health promotion and education services at convenient locations within the CVS pharmacy chain in the United States. Establishment of the CVS Health Connection venture in New England; Free health services provided by Harvard Pilgrim...
- Pfizer aims for top slot after Y2K.
Dickinson, James G. // Medical Marketing & Media; Jan1999, Vol. 34 Issue 1, p30
Reports on the drugs planned by Pfizer Inc. for introduction in the year 2000. Progress of the drugs' research and development.
- Pfizer edges ahead in U.S. sales.
Dickinson, James G. // Medical Marketing & Media; May99, Vol. 34 Issue 5, p16
Reports on Pfizer Inc.'s leadership in prescription drug sales in the United States in 1999. Prescription drug sales of other pharmaceutical companies.
- Pfizer is first in long-term care.
Dickinson, James G. // Medical Marketing & Media; Sep99, Vol. 34 Issue 9, p30
Reports that Pfizer Inc. has been ranked as the top pharmaceutical company that best met the needs of long-term care pharmacy executives. Categories of business operation of relevance to the executives; Top five companies.
- Rx for retaining talent: Pfizer prescribes work-life program.
Donovan, Kathleen // Employee Benefit News; Apr2001, Vol. 15 Issue 4, p51
Focuses on the success of Pfizer Incorporated's Vista Rx, the pharmaceutical industry's first flexible field force. Extent of Vista's flexible arrangement; Keys to its success; Reputation earned by Vista; Stories of how Vista enables people to balance their work and personal time.
- Symptomatic suppression.
Hewitt, Allison // Pharmaceutical Executive; Dec97, Vol. 17 Issue 12, p88
Reports the effect of the Pfizer drug ziprasidone on patients with schizophrenia. Association of the drugs with decreased probability of relapse.
- Closure of Pfizer Sandwich.
Kaplan, Claude // Applied Clinical Trials; May2011, Vol. 20 Issue 5, p19
The article reports that the closure of Pfizer Inc., a pharmaceutical research company, has indicated the loss of faith on the research & development industry (R & D) in Sandwich, England.
- REMOTE Trial Not a Remote Idea.
Henderson, Lisa // Applied Clinical Trials; Aug2011, Vol. 20 Issue 8, p10
An introduction is presented in which the editor discusses the participation of vendor Mytrus in validating the virtual process of a clinical trial initiated by Pfizer Inc.
- MORPHOSYS.PFIZER TO DEVLOP THERAPEUTIC ANTIBODIES.
Henderson, Lisa // Worldwide Biotech; Feb2004, Vol. 16 Issue 2, p6
Reports on a collaboration of MorphoSys AG with Pfizer Inc. for the development of therapeutic antibodies.
- As black market booms, Japan OKs viagra.
Herkovitz, Jon // Advertising Age International; 02/08/99, p2
No abstract available.
- Pfizer to appeal trademark verdict.
Herkovitz, Jon // Business Insurance; 10/18/99, Vol. 33 Issue 42, p64
Discloses the plans of Pfizer Inc. to contest a jury award of $147 million in damages stemming from a trademark infringement dispute.
- Pfizer, Inc. adds new facilities.
Herkovitz, Jon // Buildings; Jan1994, Vol. 88 Issue 1, p16
Reports on the opening of a new cafeteria and a clinical research building at Pfizer Inc.'s Central Research Campus in Groton, Connecticut. Features of the facilities; Designer.